BiologicsMD, Inc. is a preclinical-stage biotechnology company founded in January 2010 and based in Fayetteville, Arkansas. The company specializes in developing targeted recombinant fusion proteins aimed at treating hair loss, bone disorders, and oncology-related conditions. With a small team of approximately three employees, BiologicsMD has raised $2.72 million in funding and reported $6.1 million in revenue.
The company’s technology platform features patent-protected recombinant fusion proteins that combine an Active Domain for stimulating target receptors and a Binding Domain for localized delivery. This innovative approach allows for infrequent dosing, reducing off-target effects. BiologicsMD’s product pipeline includes Hair Cycle Stimulators for alopecia, a lead compound BMD-1141 for hair follicle restoration, and targeted treatments for osteoporosis and other severe bone conditions, as well as oncology applications. All products are currently in preclinical development stages.
Detailed Information
Fields marked — are added by the business owner once they claim this listing.